177 related articles for article (PubMed ID: 25631469)
1. Healthcare utilization and costs following newly diagnosed type-2 diabetes in Sweden: A follow-up of 38,956 patients in a clinical practice setting.
Sabale U; Bodegård J; Sundström J; Östgren CJ; Nilsson P; Johansson G; Svennblad B; Henriksson M
Prim Care Diabetes; 2015 Oct; 9(5):330-7. PubMed ID: 25631469
[TBL] [Abstract][Full Text] [Related]
2. Long-term resource use patterns and healthcare costs after myocardial infarction in a clinical practice setting: results from a contemporary nationwide registry study.
Janzon M; Henriksson M; Hasvold P; Hjelm H; Thuresson M; Jernberg T
Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):291-298. PubMed ID: 29474723
[TBL] [Abstract][Full Text] [Related]
3. Increased healthcare utilization costs following initiation of insulin treatment in type 2 diabetes: A long-term follow-up in clinical practice.
Kalkan A; Bodegard J; Sundström J; Svennblad B; Östgren CJ; Nilsson PN; Johansson G; Ekman M
Prim Care Diabetes; 2017 Apr; 11(2):184-192. PubMed ID: 27894781
[TBL] [Abstract][Full Text] [Related]
4. Weight change patterns and healthcare costs in patients with newly-diagnosed type-2 diabetes in Sweden.
Sabale U; Bodegard J; Svennblad B; Östgren CJ; Johansson G; Ekman M; Henriksson M; Nilsson P
Prim Care Diabetes; 2017 Jun; 11(3):217-225. PubMed ID: 28389199
[TBL] [Abstract][Full Text] [Related]
5. Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
Ringborg A; Martinell M; Stålhammar J; Yin DD; Lindgren P
Int J Clin Pract; 2008 May; 62(5):708-16. PubMed ID: 18355236
[TBL] [Abstract][Full Text] [Related]
6. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.
Giorda CB; Rossi MC; Ozzello O; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Romeo F; Lucisano G; Nicolucci A;
Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523
[TBL] [Abstract][Full Text] [Related]
7. The burden of preserved ejection fraction heart failure in a real-world Swedish patient population.
Stålhammar J; Stern L; Linder R; Sherman S; Parikh R; Ariely R; Deschaseaux C; Wikström G
J Med Econ; 2014 Jan; 17(1):43-51. PubMed ID: 24066839
[TBL] [Abstract][Full Text] [Related]
8. The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden.
Ringborg A; Yin DD; Martinell M; Stålhammar J; Lindgren P
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):576-82. PubMed ID: 19491686
[TBL] [Abstract][Full Text] [Related]
9. Effect of smoking status on healthcare costs and resource utilization in patients with type 2 diabetes in routine clinical practice: a retrospective nested case-control economic study.
Sicras-Mainar A; Rejas-Gutiérrez J; Navarro-Artieda R; Ibánez-Nolla J
Eur Addict Res; 2014; 20(2):94-104. PubMed ID: 24192535
[TBL] [Abstract][Full Text] [Related]
10. Healthcare and economic impact of diarrhea in patients with carcinoid syndrome.
Broder MS; Chang E; Romanus D; Cherepanov D; Neary MP
World J Gastroenterol; 2016 Feb; 22(6):2118-25. PubMed ID: 26877616
[TBL] [Abstract][Full Text] [Related]
11. Long-term cardiovascular outcome, use of resources, and healthcare costs in patients with peripheral artery disease: results from a nationwide Swedish study.
Hasvold P; Nordanstig J; Kragsterman B; Kristensen T; Falkenberg M; Johansson S; Thuresson M; Sigvant B
Eur Heart J Qual Care Clin Outcomes; 2018 Jan; 4(1):10-17. PubMed ID: 28950310
[TBL] [Abstract][Full Text] [Related]
12. The societal cost of schizophrenia in Sweden.
Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
[TBL] [Abstract][Full Text] [Related]
13. Resource Use and Costs up to Two Years Post Diagnosis Among Newly Diagnosed COPD Patients in the UK Primary Care Setting: A Retrospective Cohort Study.
Punekar YS; Wurst K; Shukla A
COPD; 2015 Jun; 12(3):267-75. PubMed ID: 25093809
[TBL] [Abstract][Full Text] [Related]
14. Resource utilization and cost of heart failure associated with reduced ejection fraction in Swedish patients.
Stålhammar J; Stern L; Linder R; Sherman S; Parikh R; Ariely R; Wikström G
J Med Econ; 2012; 15(5):938-46. PubMed ID: 22510016
[TBL] [Abstract][Full Text] [Related]
15. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
[TBL] [Abstract][Full Text] [Related]
16. Resource allocation and organisational features in Swedish primary diabetes care: Changes from 2006 to 2013.
Husdal R; Rosenblad A; Leksell J; Eliasson B; Jansson S; Jerdén L; Stålhammar J; Steen L; Wallman T; Adolfsson ET
Prim Care Diabetes; 2017 Feb; 11(1):20-28. PubMed ID: 27578488
[TBL] [Abstract][Full Text] [Related]
17. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
[TBL] [Abstract][Full Text] [Related]
18. Trend and factors associated with healthcare use and costs in type 2 diabetes mellitus: a decade experience of a universal health insurance program.
Cheng JS; Tsai WC; Lin CL; Chen L; Lang HC; Hsieh HM; Shin SJ; Chen T; Huang CT; Hsu CC
Med Care; 2015 Feb; 53(2):116-24. PubMed ID: 25517075
[TBL] [Abstract][Full Text] [Related]
19. Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation.
Ladapo JA; David G; Gunnarsson CL; Hao SC; White SA; March JL; Reynolds MR
J Cardiovasc Electrophysiol; 2012 Jan; 23(1):1-8. PubMed ID: 21777324
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
